Johnson & Johnson在投资者持有权的混合变化中击败了Q1的收入,提高了股息。 Johnson & Johnson beat Q1 earnings, raised dividend, amid mixed investor holdings changes.

强生（JNJ）在2025年第一季度看到Elevation Wealth Partners和Unigestion Holding SA的股票持有量减少，但InvesTrust的股票持有量有所增加。 Johnson & Johnson (JNJ) saw reduced stock holdings by Elevation Wealth Partners and Unigestion Holding SA but an increase by InvesTrust in Q1 2025. JNJ比预期收入高出2.77 EPS,并宣布季度红利从1.24美元上调1.30美元。 JNJ beat earnings expectations with $2.77 EPS and announced a higher quarterly dividend of $1.30, up from $1.24. 医疗保健公司的市场上限为3 738.3亿美元,红利收益为3.35%。 The healthcare company has a market cap of $373.83 billion and a dividend yield of 3.35%.